New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Alzheimer 'tau' protein far surpasses amyloid in predicting toll on brain tissue

Alzheimer 'tau' protein far surpasses amyloid in predicting toll on brain tissue

by University of California, San FranciscoPET scan of a human brain with Alzheimer's disease. Credit: public domainBrain imaging of pathological tau-protein "tangles" reliably predi
Neurology April 02,2024
Alzheimer 'tau' protein far surpasses amyloid in predicting toll on brain tissue

Alzheimer 'tau' protein far surpasses amyloid in predicting toll on brain tissue

by University of California, San FranciscoPET scan of a human brain with Alzheimer's disease. Credit: public domainBrain imaging of pathological tau-protein "tangles" reliably predi
Neurology April 02,2024
Tau protein changes correlate with Alzheimer's disease dementia stage

Tau protein changes correlate with Alzheimer's disease dementia stage

by Alice McCarthy,Children's Hospital BostonPET scan of a human brain with Alzheimer's disease. Credit: public domainResearch into Alzheimer's disease has long focused on understandi
Neurology April 02,2024
Tau protein changes correlate with Alzheimer's disease dementia stage

Tau protein changes correlate with Alzheimer's disease dementia stage

by Alice McCarthy,Children's Hospital BostonPET scan of a human brain with Alzheimer's disease. Credit: public domainResearch into Alzheimer's disease has long focused on understandi
Neurology April 02,2024
What happens around an Alzheimer plaque?

What happens around an Alzheimer plaque?

by VIB (the Flanders Institute for Biotechnology)PET scan of a human brain with Alzheimer's disease. Credit: public domainThe brains of people living with Alzheimer's are riddled with pla
Neurology April 02,2024
What happens around an Alzheimer plaque?

What happens around an Alzheimer plaque?

by VIB (the Flanders Institute for Biotechnology)PET scan of a human brain with Alzheimer's disease. Credit: public domainThe brains of people living with Alzheimer's are riddled with pla
Neurology April 02,2024
Tau protein suppresses neural activity in mouse models of Alzheimer's disease

Tau protein suppresses neural activity in mouse models of Alzheimer's disease

by Massachusetts General HospitalPET scan of a human brain with Alzheimer's disease. Credit: public domainA study from Massachusetts General Hospital (MGH) investigators sheds new light on ho
Neurology April 02,2024
Tau protein suppresses neural activity in mouse models of Alzheimer's disease

Tau protein suppresses neural activity in mouse models of Alzheimer's disease

by Massachusetts General HospitalPET scan of a human brain with Alzheimer's disease. Credit: public domainA study from Massachusetts General Hospital (MGH) investigators sheds new light on ho
Neurology April 02,2024
Commonly used drug for Alzheimer's disease doubles risk of hospitalization

Commonly used drug for Alzheimer's disease doubles risk of hospitalization

by Canadian Medical Association JournalPET scan of a human brain with Alzheimer's disease. Credit: public domainA drug commonly used to manage symptoms of Alzheimer disease and other dementia
Neurology April 02,2024
Commonly used drug for Alzheimer's disease doubles risk of hospitalization

Commonly used drug for Alzheimer's disease doubles risk of hospitalization

by Canadian Medical Association JournalPET scan of a human brain with Alzheimer's disease. Credit: public domainA drug commonly used to manage symptoms of Alzheimer disease and other dementia
Neurology April 02,2024
Alzheimer's, related disorders and language: How we talk about 'dementia' is key to building community bridges

Alzheimer's, related disorders and language: How we talk about 'dementia' is key to building community bridges

by Arnaud Francioni, Melissa Park, Patricia Belchior, Thomas Valente,The ConversationCredit: Pixabay/CC0 Public DomainPeople living withAlzheimer's diseaseand other related disor
Neurology April 02,2024
Alzheimer's, related disorders and language: How we talk about 'dementia' is key to building community bridges

Alzheimer's, related disorders and language: How we talk about 'dementia' is key to building community bridges

by Arnaud Francioni, Melissa Park, Patricia Belchior, Thomas Valente,The ConversationCredit: Pixabay/CC0 Public DomainPeople living withAlzheimer's diseaseand other related disor
Neurology April 02,2024
Alzheimer's disease: The identification of 75 genetic risk factors brings new insights

Alzheimer's disease: The identification of 75 genetic risk factors brings new insights

by Institut National de la Sante et de la Recherche MedicaleCredit: Pixabay/CC0 Public DomainIdentifying genetic risk factors for Alzheimer's disease is essential if we are to improve our und
Neurology April 02,2024
Alzheimer's disease: The identification of 75 genetic risk factors brings new insights

Alzheimer's disease: The identification of 75 genetic risk factors brings new insights

by Institut National de la Sante et de la Recherche MedicaleCredit: Pixabay/CC0 Public DomainIdentifying genetic risk factors for Alzheimer's disease is essential if we are to improve our und
Neurology April 02,2024
Wegovy and Ozempic: Could the new weight-loss drug also treat dementia?

Wegovy and Ozempic: Could the new weight-loss drug also treat dementia?

by Tim Viney and Barbara Sarkany,The ConversationCredit: Pixabay/CC0 Public DomainOver55 million people worldwide have dementia. This mind-robbing condition has a huge impact on society an
Neurology April 02,2024
Wegovy and Ozempic: Could the new weight-loss drug also treat dementia?

Wegovy and Ozempic: Could the new weight-loss drug also treat dementia?

by Tim Viney and Barbara Sarkany,The ConversationCredit: Pixabay/CC0 Public DomainOver55 million people worldwide have dementia. This mind-robbing condition has a huge impact on society an
Neurology April 02,2024
Structural study points the way to better malaria drugs

Structural study points the way to better malaria drugs

by Weill Cornell Medical CollegeStructure of Pf20Sβ6A117Dwith WLW-vs.aOverall structure of the Pf20Sβ6A117D–WLW-vs complex. The four bound inhibitor molecules are shown in orang
Public Health & Prevention April 02,2024
Structural study points the way to better malaria drugs

Structural study points the way to better malaria drugs

by Weill Cornell Medical CollegeStructure of Pf20Sβ6A117Dwith WLW-vs.aOverall structure of the Pf20Sβ6A117D–WLW-vs complex. The four bound inhibitor molecules are shown in orang
Public Health & Prevention April 02,2024
Intravesical gemcitabine/docetaxel as an alternative therapy for patients with non-muscle-invasive bladder cancer

Intravesical gemcitabine/docetaxel as an alternative therapy for patients with non-muscle-invasive bladder cancer

by Michael A. O'Donnell and Mohamad Abou Chakra , Medical XpressNMIBC: non-muscle invasive bladder cancer; BCG: Bacillus Calmette-Guérin; Gem: gemcitabine; Doce: docetaxel. Parts of the figure wer
Oncology April 02,2024
Intravesical gemcitabine/docetaxel as an alternative therapy for patients with non-muscle-invasive bladder cancer

Intravesical gemcitabine/docetaxel as an alternative therapy for patients with non-muscle-invasive bladder cancer

by Michael A. O'Donnell and Mohamad Abou Chakra , Medical XpressNMIBC: non-muscle invasive bladder cancer; BCG: Bacillus Calmette-Guérin; Gem: gemcitabine; Doce: docetaxel. Parts of the figure wer
Oncology April 02,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com